Twist Bioscience

Twist Bioscience: Convertible Note Funding Round

Twist Bioscience has successfully raised $200M in Convertible Note funding, reaching a valuation of $4B.

Company Overview

Synthetic DNA manufacturing

Funding Details

The Convertible Note round was led by Temasek Holdings, with participation from Fidelity, Paladin Capital Group, Casdin Capital.

Company Information

• Headquarters: 681 Gateway Boulevard, South San Francisco, CA 94080
• Founded: 2013
• Employees: 600+
• Category: Biotech

Investment

Twist Bioscience plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

• Temasek Holdings: Verified investor in Convertible Note
• Fidelity: Verified investor in Convertible Note
• Paladin Capital Group: Verified investor in Convertible Note
• Casdin Capital: Verified investor in Convertible Note